Wambolt & Associates’s Lam Research LRCX Stock Holding History

Wambolt & Associates’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,650	Closed	-$281K	–	203
2024 Q2	$281K	Hold	2,650	–	–	0.08%	171
2024 Q1	$260K	Buy	+2,650	New	+$233K	0.08%	198

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wambolt & Associates's LRCX Position: Q3 2024 in Review

Wambolt & Associates sold out of Lam Research (LRCX) in Q3 2024, closing a stake of 2,650 shares — an estimated $281K sold.

Wambolt & Associates first reported a position in LRCX in Q1 2024 and held it in 2 quarters. The position peaked at $281K in Q2 2024. 1,464 funds tracked by Wall St. Rank hold LRCX as of Q3 2024.

Wambolt & Associates reported no remaining Lam Research position as of Q3 2024 after selling out during the quarter.
Wambolt & Associates sold 2,650 Lam Research shares in Q3 2024, an estimated $281K.
Wambolt & Associates first reported a position in Lam Research in Q1 2024 and held it in 2 quarters.
Wambolt & Associates's Lam Research position peaked at $281K in Q2 2024.
1,464 funds tracked by Wall St. Rank held Lam Research as of Q3 2024.

Based on Wambolt & Associates's 13F filing for Q3 2024, filed 12 Nov 2024.